The EpiVacCorona vaccine is effective against all dangerous mutations of the novel coronavirus, including the Delta and Delta Plus strains, head of the Vector State Research Center of Virology and Biotechnology Rinat Maksyutov said on …
Just one day will be enough to update Russia's EpiVacCorona vaccine to ensure protection against new mutations of the coronavirus, the Russian State Research Center of Virology and Biotechnology Vector's General Director …
According to Rinat Maksyutov, Director General of the Vector Center for Virology and Biotechnology, the formation of lifelong immunity to coronavirus is possible. Maksyutov believes that people who have had a severe form of coronavirus …
The Vector State Center for Virology and Biotechnology (Vector Institute) plans to begin clinical trials of its coronavirus vaccine in late June this year, the Center’s CEO Rinat Maksyutov said, adding that the Institute picked three …
